[go: up one dir, main page]

WO2020091180A3 - Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient - Google Patents

Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient Download PDF

Info

Publication number
WO2020091180A3
WO2020091180A3 PCT/KR2019/007320 KR2019007320W WO2020091180A3 WO 2020091180 A3 WO2020091180 A3 WO 2020091180A3 KR 2019007320 W KR2019007320 W KR 2019007320W WO 2020091180 A3 WO2020091180 A3 WO 2020091180A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
active ingredient
probiotics
composition
secondary osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2019/007320
Other languages
French (fr)
Korean (ko)
Other versions
WO2020091180A2 (en
WO2020091180A9 (en
Inventor
이인옥
박나현
김병국
이철상
김세헌
최인석
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CKD Bio Corp
Korea University Research and Business Foundation
Original Assignee
CKD Bio Corp
Korea University Research and Business Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CKD Bio Corp, Korea University Research and Business Foundation filed Critical CKD Bio Corp
Publication of WO2020091180A2 publication Critical patent/WO2020091180A2/en
Publication of WO2020091180A3 publication Critical patent/WO2020091180A3/en
Publication of WO2020091180A9 publication Critical patent/WO2020091180A9/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention provides a Lactobacillus fermentum SRK414 strain with accession number KCTC13687BP, and pharmaceutical and food compositions comprising, as an active ingredient, the strain or a culture thereof. The strain according to the present invention and the culture thereof have an excellent effect in preventing, alleviating, or treating osteoporosis, particularly secondary osteoporosis, and thus can be usefully employed in food and pharmaceutical compositions for said purpose.
PCT/KR2019/007320 2018-10-30 2019-06-18 Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient Ceased WO2020091180A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180131027A KR20200049999A (en) 2018-10-30 2018-10-30 Composition for Preventing or Treating Secondary Osteoporosis Comprising Probiotics
KR10-2018-0131027 2018-10-30

Publications (3)

Publication Number Publication Date
WO2020091180A2 WO2020091180A2 (en) 2020-05-07
WO2020091180A3 true WO2020091180A3 (en) 2020-07-23
WO2020091180A9 WO2020091180A9 (en) 2021-02-18

Family

ID=70462259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/007320 Ceased WO2020091180A2 (en) 2018-10-30 2019-06-18 Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient

Country Status (2)

Country Link
KR (1) KR20200049999A (en)
WO (1) WO2020091180A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12274719B2 (en) * 2019-06-25 2025-04-15 Synbio Tech Inc. Method for improving walking capacity of elderly subjects
CN111419882B (en) * 2020-05-26 2022-07-29 北京科拓恒通生物技术股份有限公司 Bifidobacterium lactis for preventing and treating osteoporosis and application thereof
CN111718873B (en) * 2020-06-19 2022-09-06 江南大学 Lactobacillus fermentum with effect of relieving osteoporosis and application thereof
JP2023095344A (en) * 2021-12-24 2023-07-06 サンスター株式会社 Composition containing lactic acid bacteria
KR102542996B1 (en) * 2022-11-02 2023-06-14 주식회사 종근당바이오 Composition for preventing, alleviating, or treating cognitive impairment and Alzheimer's disease comprising Lactobacillus fermentum SRK414 strain
CN116058469B (en) * 2023-03-06 2023-06-27 天津创源生物技术有限公司 Preparation method and application of fermented lactobacillus mucilaginosus IOB802 fermented metapowder
KR102708544B1 (en) 2023-10-31 2024-09-23 주식회사 오라틱스 Pharmaceutical composition for preventing or treating bone disease containing Weissella cibaria CMU (oraCMU) or Weissella cibaria CMS1 (oraCMS1) as an active ingredient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120263695A1 (en) * 2009-08-11 2012-10-18 Jurgen Schrezenmeir Composition having strains of lactobacillus fermentum
KR20130002543A (en) * 2011-06-29 2013-01-08 주식회사 쎌바이오텍 Composition for preventing or treating osteoporosis comprising multi-species pobiotic mixture
KR20130101661A (en) * 2012-02-27 2013-09-16 한국식품연구원 Method for preparing vitamin k2 and fermented milk using lactobacillus fermentum lc272
KR20170028486A (en) * 2015-09-03 2017-03-14 호서대학교 산학협력단 Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120263695A1 (en) * 2009-08-11 2012-10-18 Jurgen Schrezenmeir Composition having strains of lactobacillus fermentum
KR20130002543A (en) * 2011-06-29 2013-01-08 주식회사 쎌바이오텍 Composition for preventing or treating osteoporosis comprising multi-species pobiotic mixture
KR20130101661A (en) * 2012-02-27 2013-09-16 한국식품연구원 Method for preparing vitamin k2 and fermented milk using lactobacillus fermentum lc272
KR20170028486A (en) * 2015-09-03 2017-03-14 호서대학교 산학협력단 Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MOON, Y.-I. ET AL.: "Functionality of Dairy Foods on Osteoporosis", JOURNAL OF MILK SCIENCE AND BIOTECHNOLOGY, vol. 34, no. 3, 2016, pages 157 - 164, XP055727431 *

Also Published As

Publication number Publication date
WO2020091180A2 (en) 2020-05-07
WO2020091180A9 (en) 2021-02-18
KR20200049999A (en) 2020-05-11

Similar Documents

Publication Publication Date Title
WO2020091180A3 (en) Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient
WO2020091179A3 (en) Composition for preventing or treating secondary osteoporosis comprising probiotics as active ingredient
IL289610A (en) Bifidobacterium bifidum bacterial strain, the compositions thereof and related uses
NZ737752A (en) Compositions comprising bacterial strains
EP4484581A3 (en) Akkermansia muciniphila eb-amdk19 strain and use thereof
EP4086334A4 (en) Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases containing same
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
WO2016086210A8 (en) Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease
WO2018165765A9 (en) Probiotic molecules for reducing pathogen virulence
EP4086335A4 (en) Lactobacillus fermentum strain, and composition for preventing or treating metabolic diseases, comprising same
PT3412766T (en) Lactobacillus salivarius strain, composition comprising the same, and uses thereof
MX2024008447A (en) Bacillota strains with improved outgrowth.
MX383749B (en) PROBIOTIC STRAINS WITH THE ABILITY TO ABSORB CHOLESTEROL, METHODS AND USES OF THEM
AU2016100865A4 (en) Multi-strain probiotic composition
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
WO2018135843A3 (en) Lactobacillus fermentum strain having ability to prevent hair loss, promote hair growth, or improve sexual function and composition comprising same
EE201400038A (en) Composition comprising a probiotic microorganism strain Lactobacillus plantarum Inducia DSM 21379 as hypocholesterolemic and antimicrobial agent for use in preventing cardiovascular disorders Clostridium difficile associated diarrhoea
EP4360625A3 (en) Prebiotic and probiotic treatment to reduce oral dysbiosis and promote eubiosis
WO2015121458A3 (en) Use of compositions comprising bifidobacterium animalis ssp. lactis lmg p-28149
WO2018004224A3 (en) Novel sporichthyaceae microorganism and use thereof
GB201905386D0 (en) Probiotic compositions and uses thereof
PH12019502699A1 (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp17 strain and use thereof
SG11202106147RA (en) Lactobacillus fermentum wikim0102 having anti-cancer activity and composition comprising the same as active ingredient
SG11202000113QA (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof
WO2020074569A8 (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19879988

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19879988

Country of ref document: EP

Kind code of ref document: A2